How do investment vehicles and innovations work together to deliver better health care?

UNAIDS, ICV, Johnson & Johnson, BD and the Center for Global Health and Diplomacy are hosting a forum entitled Transformational Aid for Development Forum in order to create connections for scaling up innovations and investments for health and to reach vulnerable populations.

The Transformational Aid for Development forum will initiate a discussion with heads of United Nations agencies, chief executive officers of investment firms, ministers of health and representatives of the private sector, including from the pharmaceutical, diagnostics, information technology and investment sectors. These stakeholders will answer the question, “How do investment vehicles and innovations work together to deliver better health care to millions of people across the globe?”

During this one-day strategic forum, government ministers will describe the gaps and challenges they face in their respective countries, chief executive officers from family offices and investment firms will discuss which sectors they intend to invest in and private sector representatives will discuss where they will implement new technologies, diagnostics and pharmaceuticals.

Strategies to Forge Innovative Partnerships in Global Health

The environment has never been more conducive to forging new partnerships between public and private sector actors. The Sustainable Development Goals calls for individuals, governments, institutions, and firms to work together, and the private sector’s interests to contribute to development efforts grows each day. Partnership development, however, remains a difficult enterprise due to different and sometimes competing objectives and intentions. For instance, how can outcomes- and results-based approaches co-exist with growth- and profit-oriented objectives? How can accountability to the taxpayers be achieved within the framework of accountability to shareholders and investors? Is it even possible to quantify and monetize efforts that aim to “save lives”?

This plenary will focus on the challenges in creating public-private sector partnerships within the global health sphere. Participants will share their experiences and lessons while also discussing the critical conditions and elements needed to achieve success in areas such as blended financing, service delivery, and research and development.


  • Gary M. Cohen is Executive Vice President of BD. He is board chair of the CDC Foundation and a board director of the Perrigo Company, UNICEF USA, GBC Health and the Accordia Global Health Foundation. He also serves as a Commissioner for the UN Commission on Life Saving Commodities for Women and Children, chair of the CDC/Corporate Roundtable on Global Health Threats and an advisor to the Clinton Global Initiative. Gary and the BD team are extensively engaged in collaborations across the public, private and NGO sectors to address health needs in developing and emerging countries. He has served as an advocate, speaker and expert panelist on global health, child immunization, HIV/AIDS and health system strengthening, in venues including the United Nations, World Bank, World Economic Forum (Davos), US Department of State and Council on Foreign Relations. Gary founded Together for Girls, a new partnership to address the human rights and public health impacts of sexual violence against girls, comprised of UNICEF, UNAIDS, UNFPA, UN Women, the World Health Organization, the CDC, the US Department of State – Office of the US Global AIDS Coordinator (PEPFAR) and Office of Global Women’s Issues (GWI), the Nduna Foundation, BD and other partners. He has been honored for his humanitarian work by MESAB (Medical Education for South African Blacks), B’nai B’rith International, UNICEF USA, the Nyumbani Home (an orphanage in Kenya for HIV positive children) and the Dikembe Mutombo Foundation. He earned a BA from Rutgers College and a MBA from the Rutgers Graduate School of Management, and previously served on the university’s Board of Trustees.
  • Ndaba Mandela is Chairman of Africa Rising Foundation. Nelson Mandela had a “long walk to freedom”, yet his footprints still remain. Following in the footsteps of his beloved and iconic grandfather, Ndaba Mandela has taken the torch – and ran with it. Today, Nelson Mandela’s legacy continues as Ndaba keeps its beacon of hope bright, fueling its fiery message that one person can make a difference. Thankfully for all, the legacy lives, as Ndaba was recently named one of the “28 Men of Change” by BET. Today, Ndaba is showing the world, through his actions and orations, that Nelson Mandela’s voice and message of freedom still carries and rings true – sounded by a child that became a man under the warm embrace and expert tutelage of one of history’s greatest teachers. He continues to keep Mandela on the world’s mind.


“I carry with me the values of my grandfather. I am an African, and I know what it means to be African, and I’m proud of it.”

 – Ndaba Mandela


  • Joanne Manrique is President of Global Health and Diplomacy. Joanne is also president of International Development Strategies and is the former executive director of the Susan G. Komen Global Health Alliance. She has advised multiple global leaders, including Senator John Kerry and Sarah Brown, former first lady of the United Kingdom, on global health issues. Ms. Manrique holds a master’s in international relations from the University of Maryland and a M.P.H. and doctorate from George Washington University.
  • Michel Sidibé is Executive Director of UNAIDS and holds the rank of Under-Secretary-General of the United Nations. Mr Sidibé currently chairs the H6, a partnership that unites and leverages the mandates of six United Nations agencies to deliver on an integrated agenda for the health and well-being of women, children and adolescents. Mr Sidibé’s vision of zero new HIV infections, zero discrimination and zero AID-related deaths has helped drive recent progress in the AIDS response. The goal of having 15 million people living with HIV on antiretroviral therapy by the end of 2015 was achieved nine months ahead of schedule. Access to these life-saving medicines has continued to expand, with 18.2 million people on treatment by mid-2016. Under his leadership of UNAIDS, more and more countries have adopted a Fast-Track approach through which the achievement of a set of measurable targets by 2020 will set the world on course to end the AIDS epidemic as a public health threat by 2030 within the framework of the Sustainable Development Goals. Today, a growing number of countries are also adopting the 90–90–90 targets, whereby 90% of people living with HIV know their status, 90% of people who know their status are accessing treatment and 90% of people on treatment have a suppressed viral load. Mr Sidibé’s leadership in calling for the elimination of new HIV infections among children has contributed to a 60% reduction since 2009 in new paediatric HIV infections in the 21 priority countries of the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. His idea of shared responsibility and global solidarity has been embraced by the international community. This has encouraged an increased ownership of their epidemics by the countries most affected, with domestic resources now accounting for 57% of global AIDS spending. Mr Sidibé’s commitment to advancing global health began in his native Mali, where he worked to improve the health and welfare of the nomadic Tuareg people. He later became Country Director for Terre des Hommes. In 1987, Mr Sidibé joined the United Nations Children’s Fund (UNICEF) in the Democratic Republic of the Congo and went on to serve with UNICEF for 14 years, overseeing programmes across 10 francophone African countries and serving as a country representative in a number of countries. Mr Sidibé’s work has earned him widespread recognition. He has been awarded honorary doctorates from Tuskegee University, Clark University, the University of British Columbia and KwaZulu-Natal University. Since 2007, he has held an honorary professorship at Stellenbosch University. In 2017, he was awarded the Emory President’s Medal in recognition of his work as a “passionate champion for health and humanity.” In 2012, he was named as one of the 50 most influential Africans by the Africa Report and, in 2009, as one of 50 personalities of the year by the French newspaper Le Monde. He is a Knight of the National Order of the Legion of Honour of France, an Officer of the National Order of Mali, an Officer of the National Order of Benin and a Chancellor of the National Order of Chad. He has been awarded an Order of Saint-Charles by Monaco.
  • Anthony Recchia is Founder and Chief Executive Officer of EchoStone Housing System, a company that provides an innovative housing system developed specifically to address housing shortages worldwide. Mr. Recchia has more than 25 years experience in private equity and global business development and is a partner in a private investment company, Eastover Investments and Management LLC. Prior to joining EchoStone, he was a partner in a physical commodity trading company, Global Commodity Trade and Finance. Mr. Recchia received a Bachelor of Science in Economics from Northeastern University.
  • Robert Smith is the founder of ICV. He entered Wall Street over 20 years ago with lessons passed down from four generations of family members who worked in the investment industry before him. For more than a decade, Robert has allocated capital on behalf of and co-invested with Family Offices. Over the course of his career, he managed sales and trading teams at leading financial institutions, where he built a Fund Investor network and led in profitability at three firms: once while working in a trading capacity at the world’s largest market making firm and twice while working in an equity capital markets capacity at boutique investment banks. In 2014, Robert founded ICV to bring together his network of Family Offices and Fund Investors to evaluate opportunities that create a social impact beyond a financial return. Robert serves as Business Strategy Advisor to New Frontier Bio, a multi-asset holding company, which leverages the long-term involvement of the Kennedy family in healthcare to identify, finance and develop novel medical technologies from inception through clinical proof of concept. He serves as a member of the President’s Advisory Board of Thomas Jefferson University and Jefferson Health, 16th on U.S. News & World Report’s 2017-2018 Best Hospitals Honor Roll. Robert is Senior Advisor for Fundraising and Partnerships to the Permanent Secretariat of the World Summit of Nobel Peace Laureates, a platform to consolidate peace efforts and strengthen global security, monitor and support the Nobel Peace Laureates, and engage the minds of young people and citizens on real matters that broaden vision and open up new horizons for more peaceful and compassionate thinking. He is a member of the Advisory Council of Represent.Us, which brings the left and the right together to create positive change for American democracy. He serves as a member of the board of organizations focused on youth development, including the Chaeli Foundation, Childhood Cancer Kids, The Children’s Village and Tuesday’s Children. Robert is Vice President and serves on the Board of Directors of the Harmon Foundation, a private foundation established in 1922 by his great, great grandfather, William E. Harmon, who operated the largest real estate company in the world at the turn of the 20th century, created the mortgage and college loans, fueled the Harlem Renaissance and donated to thousands of nonprofits over his lifetime “to bring smiles and tender thoughts to the great in heart in high and low places, and to comfort and cheer those who do exceptional things or suffer.”
  • Jami Taylor is senior director, global public health systems policy and partnerships at Johnson & Johnson. Taylor’s responsibilities include the establishment of novel collaborations with governments, multilaterals, and civil society around shared priorities in global public health. A recognized expert in innovative financing for global health and development, Taylor secured a signature blended finance collaboration between J&J and Canada’s Department of Foreign Affairs, Trade, and Development in 2015, which was highlighted at the Global Financing for Development conference in Addis Ababa that year. In 2016, Taylor co-founded and launched Financing & Innovation in Global Health, a platform connecting hundreds of stakeholders across sectors toward more efficient combinations and deployment of resources in the global health field.

Good Health and Well-Being. Ensuring healthy lives and promoting the well-being for all at all ages is essential to sustainable development.

Significant strides have been made in increasing life expectancy and reducing some of the common killers associated with child and maternal mortality. Major progress has been made on increasing access to clean water and sanitation, reducing malaria, tuberculosis, polio and the spread of HIV/AIDS. However, many more efforts are needed to fully eradicate a wide range of diseases and address many different persistent and emerging health issues.

Examining the Challenges and Opportunities Related to the Financing, Development, and Scale-up of Innovations

“There is never a shortage of ideas” is a refrain often heard when it comes to innovations and global health. From major pharmaceutical companies to individual researchers and inventors, new approaches, techniques, tools, and equipment are being created every day. For developers, questions often asked are, “How do I get my ideas heard, funded, and tested?” “How can I work with others who may have similar ideas or can assist with implementation and rolling out?” “After my invention has been proven to be effective, how can it be scaled up?”

On the other side of the equation, countries are expressed concerns that there are too many ideas being delivered too quickly. For many low- to middle-income countries, it takes several years to full integrate a new technology, a piece of equipment, or new approach because health professionals and workers need to be informed and educated about the new tool, systems need to be adjusted, and this new resource must be evaluated. With the flood of ideas, countries cannot keep up, yet at the same time they need advice on what item is the most effective and efficient to respond to their unique needs.

This plenary will examine the challenges and opportunities related to the financing, development, and scale-up of innovations. The perspectives of financers, innovators, and countries will be shared to provide a balance perspective – i.e., the supply and demand side of the equation.


  • Brian Annechino is Director of the Government & Public Sector at iVEDiX, a platform that allows you to experience your data in real-time – combining actionable analytics, personalized workflows, and IoT location intelligence. iVEDiX ties the enterprise together, in a single pane of glass. Brian operates in the Middle East, Europe and Africa expanding the global footprint for iVEDiX.
  • Aron Betru is managing director of the Center for Financial Markets at the Milken Institute, where he leads strategic initiatives focused on expanding and leveraging resources to enhance social impact. Prior to joining the Institute, Betru was co-founder and CEO of Financing for Development, where he pioneered ways to leverage guarantee-backed financing of public health commodities, mobilizing millions of dollars in commercial lending for malaria and trade financing for reproductive health. Betru has had international development roles at the United Nations Foundation and Dalberg Global Development Advisors as well as private-sector experience at McKinsey & Co. and Goldman Sachs. A member of the Council on Foreign Relations and a regular contributor to Global Health and Diplomacy magazine, Betru holds a B.A. in economics and international studies from Northwestern University, an M.B.A. from Columbia University and an M.A. from the Johns Hopkins School of Advanced International Studies.
  • Michelle Clements is President of Synergy Trust Partners, a single family office. Michelle is a sought-after speaker focused on creating new family offices, trust companies, and non-profit organizations. She is skilled at educating and involving next-generation family in family office leadership by creating comprehensive curricula and effective communication across generations. Michelle is also skilled at developing strategies for turning around underperforming organizations and creating processes and documentation for start-up family offices. She possess an extensive network of exclusive financial and non-financial service resources for families and a talent for anticipating and resolving issues faced by families. Michelle studied Wealth Management at Stanford University’s Executive Education Program and at the Cannon Financial Institute. She was awarded the Institutional Investor/Gleneagles Group Family Office Executive of the Year Award in 2013.
  • Anders Lindquist is Founder and President, Business Development of EchoStone Housing System, a company that provides an innovative housing system developed specifically to address housing shortages worldwide. Anders has more than 30 years experience in investment securities and banking. Prior to joining EchoStone, he served as President of Swedbank First Securities, President of Nordic Partners, and President of Aros. Mr. Lindquist received his university education at Institut de Diavox, Lausanne and achieved the prestigious rank of Navy Seal in the Royal Swedish Navy.
  • Dr. Luiz Loures is Deputy Executive Director, Programme, UNAIDS and Assistant Secretary-General of the United Nations. Luiz Loures joined UNAIDS in 1996 and was appointed Deputy Executive Director of Programme and Assistant Secretary-General of the United Nations in January 2013. He leads UNAIDS’ efforts in leveraging critical support to countries to reach the end of AIDS by 2030. Dr. Loures is a medical doctor with nearly 30 years’ experience in the AIDS response. His engagement has ranged from providing medical care to people living with HIV in the early days of the epidemic––to his dynamic involvement in global policy framework development today. In 2006, Dr Loures was granted the Make a Difference Award for his long-standing contribution to the global response to AIDS by O Globo, one of Brazil’s largest newspapers. Previously, Dr. Loures was Director of the Political and Public Affairs Branch of UNAIDS where he managed strategic and political processes to promote UNAIDS’ vision and enable effective implementation of the corporate agenda. Prior to this, Dr Loures was the Director of UNAIDS’ Executive Office, overseeing strategic direction and assisting the Executive Director in implementing the UNAIDS strategy. He also managed UNAIDS’ activities in the Americas and Europe as the Associate Director of the Country and Regional Support Department. Before joining UNAIDS Dr Loures participated actively in the creation and consolidation of Brazil’s National AIDS Programme—which is widely recognized today as being one of the most effective in curbing the epidemic. Dr Loures was directly responsible for designing the programme for universal access to antiretroviral therapy for people living with HIV in Brazil. In the early 1980’s as a pioneer in the AIDS response, Dr. Loures diagnosed some of the first patients with AIDS-related illnesses in Brazil. Born, raised and educated in Brazil, Dr. Loures completed his medical studies at the Federal University of Minas Gerais, specializing in critical care. He holds an MPH degree from the University of California at Berkeley and speaks Portuguese, Spanish, English and French.
  • Joanne Manrique is President of Global Health and Diplomacy. Joanne is also president of International Development Strategies and is the former executive director of the Susan G. Komen Global Health Alliance. She has advised multiple global leaders, including Senator John Kerry and Sarah Brown, former first lady of the United Kingdom, on global health issues. Ms. Manrique holds a master’s in international relations from the University of Maryland and a M.P.H. and doctorate from George Washington University.
  • Ambassador John Simon is Vice-Chair of the Board of The Global Fund and founder and managing partner of Total Impact Capital, an impact investing firm. He has served as United States Ambassador to the African Union, and as Executive Vice President of the Overseas Private Investment Corporation (OPIC). He previously served as a senior director in the U.S. National Security Council and as Special Assistant to the President.


Innovation Showcase

At ICV Geneva 2018: Transformation Aid for Development, we will feature innovations from many different sectors, some directly related to healthcare some tangentially related to healthcare and supported by UNITAID, Finland and other G7 governments. Most of the innovations have been piloted and have commitments in the range of US$ 40-60 million.These innovations will showcase products from new methods of detecting HIV to a brand new proprietary building technique to bring affordable, quality housing to millions of people to new data platforms for healthcare in the emerging markets. This marketplace will bring together the public sector, the private sector, investors and innovators all of the components necessary to develop lasting partnerships going forward. Innovators will showcase their products during scheduled breaks and the lunch hour.



InterContinental Geneve
Chemin du Petit-Saconnex 7-9, 1209
Genève, Switzerland



07:30 AM      
InterContinental Geneve
07:30 09:30 Plenary Session I: Strategies to Forge Innovative Partnerships in Global Health  
09:30 09:45 Break
09:45 11:00 Plenary Session II: Examining the Challenges and Opportunities related to the Financing, Development and Scale-up of Innovations  
11:00 11:15 Break
07:30 8:30 Catalyzing Blended Investment in Innovation  
08:30 11:30 The Future of Health and Well-Being of Women, Children and Adolescents  
12:00 13:00 Lunch
14:00 16:00 Innovation to Impact (I2I) Marketplace  
16:00 16:10 Closing Remarks